CHAMPIONS ONCOLOGY, INC. (CSBR) earnings date, results and what the price requires
Nasdaq · SEC CIK 0000771856 · SEC filings checked Oct 16, 2026
Next report
Dec 10, 2026
Estimated from reporting history (91-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
Last close
$4.70
Polygon.io daily close, Oct 16, 2026. End of day, not live.
Trailing diluted EPS
$-0.08
Sum of quarters ending Apr 30, 2026, Jan 31, 2026, Oct 31, 2025, Jul 31, 2025
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jul 31, 2026 | Sep 10, 2026 | $15.2M | $-426,000 | — | Filing |
| Apr 30, 2026 | Jul 27, 2026 | $13.8M | $475,825 | $-0.05 | Filing |
| Jan 31, 2026 | Mar 12, 2026 | $16.6M | $-279,000 | $-0.02 | Filing |
| Oct 31, 2025 | Dec 15, 2025 | $15.0M | $268,000 | $0.02 | Filing |
| Jul 31, 2025 | Sep 15, 2025 | $14.0M | $-466,000 | $-0.03 | Filing |
| Apr 30, 2025 | Jul 23, 2025 | $12.4M | $-6.5M | $-0.12 | Filing |
| Jan 31, 2025 | Mar 11, 2025 | $17.0M | $4.5M | $0.31 | Filing |
| Oct 31, 2024 | Dec 11, 2024 | $13.5M | $728,000 | $0.05 | Filing |
What would CHAMPIONS ONCOLOGY, INC. have to report for its valuation to change?
Trailing earnings are negative, so a price-to-earnings reverse model does not apply. The model is not shown rather than filled with assumptions.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.